Pronation During Veno-venous Extra Corporeal Membrane Oxygenation

January 14, 2022 updated by: Federico Longhini, University Magna Graecia

Effects of Pronation on Respiratory System Mechanical Properties and Ventilation in Patients With Acute Respiratory Distress Syndrome During Vv-ecmo

The Acute Respiratory Distress Syndrome (ARDS) is defined by a recent (within 1 week) respiratory failure, not fully explained by cardiac failure or fluid overload. ARDS is also characterized by bilateral opacities at the chest imaging, with an alteration of the oxygenation while positive end-expiratory pressure equal or greater than 5 cmH2O is applied. Severe ARDS is characterized by a high mortality. In the most severe ARDS patients, venovenous extracorporeal membrane oxygenation (vv-ECMO) is increasingly accepted as a mean to support vital function, although not free from complications.

In patients with severe ARDS, prone position has been used for many years to improve oxygenation. In these patients, early application of prolonged (16 hours) prone-positioning sessions significantly decreased 28-day and 90-day mortality. More recently, prone position and ECMO have been coupled as concurrent treatment. Indeed, the addition of prone positioning therapy concurrently with ECMO can aid in optimizing alveolar recruitment, and reducing ventilator-induced lung injury. Nowadays, few data exist on respiratory mechanics modifications before and after the application of prone position in patients with severe ARDS receiving vv-ECMO. The investigators have therefore designed this observational study to assess the modifications of mechanical properties of the respiratory system, ventilation and aeration distribution, and hemodynamics occurring during ECMO before and after prone position in patients with severe ARDS.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

15

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Catanzaro, Italy, 88100
        • Federico Longhini

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients will receive deep sedation and continuous infusion of neuromuscular blocking agents. Protective mechanical ventilation will be set in volume-controlled mode.

A pulmonary artery catheter (PAC) will be also positioned and connected to a dedicated system for hemodynamic monitoring.

After enrolment, a silicon 16-electrode belt of proper size will be positioned around the patient's chest between the 4th and 6th intercostal spaces and connected to the EIT device. The position of EIT belt will be therefore marked on the skin with a dermographic pencil to avoid its displacement. Invasive mechanical ventilation will be applied with a ventilator connected to the EIT device through a RS232 interface.

Description

Inclusion Criteria:

  • all adult patients with a diagnosis of severe Acute Respiratory Distress Syndrome receiving veno-venous ECMO

Exclusion Criteria:

  • mechanical ventilation for 7 days or longer
  • pregnancy
  • body mass index (BMI) > 45 kg/m2
  • chronic respiratory failure with long-term oxygen therapy or domiciliary non-invasive ventilation
  • cardiac failure resulting in veno-arterial ECMO
  • history of heparin- induced thrombocytopenia
  • cancer with a life expectancy of less than 5 years
  • moribund condition or a Simplified Acute Physiology Score (SAPS-II) value of more than 90;
  • current non drug- induced coma after cardiac arrest or presence of an irreversible neurologic injury
  • decision to withhold or withdraw life--sustaining therapies
  • presence of pneumothorax and/or pulmonary emphysema
  • recent (1 week) thoracic surgery
  • presence of chest burns
  • inclusion in other research protocols
  • refusal of consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
ECMO Prone Position
After baseline assessment in supine position, patients will be positioned in prone position to assess modification of lung mechanics, aeration and hemodynamics
Pronation will be executed according to a predefined protocol: 4 caregivers will be required for the procedure, one of them being dedicated to the management of the head of the patient, the endotracheal tube and the ventilator lines. The others will stand at each side of the bed. In the first step, the direction of the rotation will be decided giving priority to the side of the central venous lines. The patient will be then moved along the horizontal plane to the opposite side of the bed selected for the direction of rotation. In the third step, the patient will be moved in the sagittal plane and maintained in that position for a short while to attach the cardiac electrodes to her/his back and to set a new bed sheet. In the last step, the patient will be turned to the complete prone position.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Driving Pressure
Time Frame: 30 minutes after the prone positioning
Difference between the airway plateau pressure and the total positive end-expiratory pressure after an inspiratory and expiratory hold maneuvers, respectively
30 minutes after the prone positioning

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Respiratory system compliance
Time Frame: 30 minutes after the prone positioning
Driving pressure to the tidal volume ratio
30 minutes after the prone positioning
Cardiac output
Time Frame: 30 minutes after the prone positioning
Liters of blood flow ejected from the heart per minute, measured through a pulmonary artery catheter
30 minutes after the prone positioning
Pulmonary arterial pressure
Time Frame: 30 minutes after the prone positioning
pulmonary arterial pressure measured through a pulmonary artery catheter
30 minutes after the prone positioning
End-Expiratory Lung Impedance
Time Frame: 30 minutes after the prone positioning
Measurement of the end expiratory lung volume, as assessed by the electrical impedance tomography
30 minutes after the prone positioning

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

February 1, 2022

Primary Completion (Anticipated)

February 28, 2023

Study Completion (Anticipated)

February 28, 2023

Study Registration Dates

First Submitted

January 3, 2022

First Submitted That Met QC Criteria

January 14, 2022

First Posted (Actual)

January 20, 2022

Study Record Updates

Last Update Posted (Actual)

January 20, 2022

Last Update Submitted That Met QC Criteria

January 14, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

Deindividualized data will be share on reasonable request to the Principal Investigator after study completion and publication

IPD Sharing Time Frame

Data will be available after study completion and publication

IPD Sharing Access Criteria

On reasonable request

IPD Sharing Supporting Information Type

  • Study Protocol

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Respiratory Distress Syndrome

Clinical Trials on Prone Position during Extra Corporeal Membrane Oxygenation (ECMO)

Subscribe